Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Mitchell

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Cancers|December 24, 2021
Therapeutic Targeting of Exportin-1 in Childhood CancerBasia Galinski, Thomas B Alexander, Daniel A Mitchell, et al.
Virology|July 31, 2007
Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectinAndrea Marzi, Daniel A Mitchell, Chawaree Chaipan, et al.
Journal of the American Chemical Society|February 27, 2014
Dendritic cell lectin-targeting sentinel-like unimolecular glycoconjugates to release an anti-HIV drugQiang Zhang, Lu Su, Jennifer Collins, et al.
Cancer Letters|February 12, 2017
A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatmentSuzanne J Dilly, Andrew J Clark, Andrew Marsh, et al.
Biomaterials Science|June 3, 2020
Ice recrystallisation inhibition by polyols: comparison of molecular and macromolecular inhibitors and role of hydrophobic unitsRobert C Deller, Thomas Congdon, Mohammed A Sahid, et al.
Structure (London, England : 1993)|November 15, 2011
Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activationAlexandre R Gingras, Umakhanth Venkatraman Girija, Anthony H Keeble, et al.
Nature Structural & Molecular Biology|June 15, 2004
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNRYuan Guo, Hadar Feinberg, Edward Conroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
C1q deficiency and autoimmunity: the effects of genetic background on disease expressionDaniel A Mitchell, Matthew C Pickering, Joanna Warren, et al.
Chemical Communications (Cambridge, England)|July 26, 2011
Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cellsMihai Ciobanu, Kuo-Ting Huang, Jean-Pierre Daguer, et al.
Frontiers in Immunology|January 10, 2017
Complement Protein C1q Interacts with DC-SIGN <i>via</i> Its Globular Domain and Thus May Interfere with HIV-1 TransmissionLina Pednekar, Hrishikesh Pandit, Basudev Paudyal, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancers|December 24, 2021
Therapeutic Targeting of Exportin-1 in Childhood CancerBasia Galinski, Thomas B Alexander, Daniel A Mitchell, et al.
Virology|July 31, 2007
Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectinAndrea Marzi, Daniel A Mitchell, Chawaree Chaipan, et al.
Journal of the American Chemical Society|February 27, 2014
Dendritic cell lectin-targeting sentinel-like unimolecular glycoconjugates to release an anti-HIV drugQiang Zhang, Lu Su, Jennifer Collins, et al.
Cancer Letters|February 12, 2017
A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatmentSuzanne J Dilly, Andrew J Clark, Andrew Marsh, et al.
Biomaterials Science|June 3, 2020
Ice recrystallisation inhibition by polyols: comparison of molecular and macromolecular inhibitors and role of hydrophobic unitsRobert C Deller, Thomas Congdon, Mohammed A Sahid, et al.
Structure (London, England : 1993)|November 15, 2011
Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activationAlexandre R Gingras, Umakhanth Venkatraman Girija, Anthony H Keeble, et al.
Nature Structural & Molecular Biology|June 15, 2004
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNRYuan Guo, Hadar Feinberg, Edward Conroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
C1q deficiency and autoimmunity: the effects of genetic background on disease expressionDaniel A Mitchell, Matthew C Pickering, Joanna Warren, et al.
Chemical Communications (Cambridge, England)|July 26, 2011
Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cellsMihai Ciobanu, Kuo-Ting Huang, Jean-Pierre Daguer, et al.
Frontiers in Immunology|January 10, 2017
Complement Protein C1q Interacts with DC-SIGN <i>via</i> Its Globular Domain and Thus May Interfere with HIV-1 TransmissionLina Pednekar, Hrishikesh Pandit, Basudev Paudyal, et al.
Pageof 6